| Price | 575.00p on 12-02-2026 at 17:15:00 |
|---|---|
| Change | -15.00p -2.54% |
| Buy | 600.00p |
| Sell | 550.00p |
| Last Trade: | Sell 1.00 at 565.00p |
| Day's Volume: | 3,374 |
| Last Close: | 575.00p |
| Open: | 590.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 575.00p - 590.00p |
| 52wk Range: | 560.00p - 1,200.00p |
| Market Capitalisation: | £89.04m |
| VWAP: | 586.89216p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1 | 565.00p | Ordinary |
16:14:00 - 12-Feb-26 |
| Buy* | 250 | 584.45p | Ordinary |
14:57:24 - 12-Feb-26 |
| Unknown* | 1,710 | 584.45p | Ordinary |
14:38:34 - 12-Feb-26 |
| Buy* | 355 | 600.00p | Ordinary |
14:31:09 - 12-Feb-26 |
| Buy* | 320 | 577.50p | Ordinary |
14:29:16 - 12-Feb-26 |
| Buy* | 51 | 584.45p | Ordinary |
14:12:07 - 12-Feb-26 |
| Buy* | 1 | 630.00p | SI Trade |
14:12:07 - 12-Feb-26 |
| Buy* | 1 | 609.75p | Ordinary |
13:28:46 - 12-Feb-26 |
| Buy* | 9 | 619.00p | Ordinary |
09:01:39 - 12-Feb-26 |
| Buy* | 1 | 627.45p | Ordinary |
08:22:02 - 12-Feb-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Feb 2026 3:58 pm | PRN | Director Dealing |
| 10th Feb 2026 7:00 am | PRN | Leadership Changes |
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
